Impaired transcallosally mediated motor inhibition in adults with attention-deficit/hyperactivity disorder is modulated by methylphenidate

Journal of Neural Transmission

Volumn 115, Issue 5, 2008, Pages 777-785

  Hoeppner, Jacqueline ^a   Wandschneider, Roland ^a   Neumeyer, Martin ^a   Gierow, Wolfgang ^a   Haessler, Frank ^a   Herpertz, Sabine C ^a   Buchmann, Johannes ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Adult ADHD; Cortical silent period (cSP); Ipsilateral silent period (iSP); Methylphenidate; Transcranial magnetic stimulation

Indexed keywords

METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERACTIVITY; MALE; NERVE EXCITABILITY; PRIORITY JOURNAL; RESTLESSNESS; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; ELECTRIC STIMULATION; EVOKED POTENTIALS, MOTOR; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; REACTION TIME; REGRESSION ANALYSIS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 44749091970     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0008-1     Document Type: Article

References (63)

1. Arnsten AF, Dudley AG (2005) Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 1:2
2. Barkley RA, Fischer M, Smallish L, Fletcher K (2002) The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 111:279-289
3. Baumgardner TL, Singer HS, Denckla MB, Rubin MA, Abrams MT, Colli MJ, Reiss AL (1996) Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 47:477-482
4. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C et al (1996) Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 35:343-351
5. Biederman J, Mick E, Faraone SV (2000) Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 157:816-818
6. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S et al (2006) A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 59:829-835
7. Buchmann J, Wolters A, Haessler F, Bohne S, Nordbeck R, Kunesch E (2003) Disturbed transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD). Clin Neurophysiol 114:2036-2042
8. Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Wittstock M, Benecke R et al (2006) Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH). Neurosci Lett 405:14-18
9. Conners CK (1999) Conners' adult ADHD rating scale. Multi-Health Systems, New York
10. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ (1999) Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354:2132-2133
11. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF, Hahn K et al (2000) Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27:1518-1524
12. DuPaul G, Power T, Anastopoulos A, Reid R (1998) Rating scale IV: checklist, norms, and clinical interpretation. Guilford, New York
13. Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy EM, Greiner AR, Altenderfer L et al (2001) Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol 9:163-175
14. Federici M, Geracitano R, Bernardi G, Mercuri NB (2005) Actions of methylphenidate on dopaminergic neurons of the ventral midbrain. Biol Psychiatry 57:361-365
15. Ferbert A, Priori A, Rothwell JC, Day BL, Colebatch JG, Marsden CD (1992) Interhemispheric inhibition of the human motor cortex. J Physiol 453:525-546
16. ® axis II personality disorders (SCID-II). American Psychiatric Press, Washington
17. Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC, Mathis CA et al (2005) Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry 58:908-912
18. Gao WJ, Krimer LS, Goldman-Rakic PS (2001) Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. Proc Natl Acad Sci USA 98:295-300
19. Garvey MA, Barker CA, Bartko JJ, Denckla MB, Wassermann EM, Castellanos FX, Dell ML et al (2005) The ipsilateral silent period in boys with attention-deficit/hyperactivity disorder. Clin Neurophysiol 116:1889-1896
20. Giedd JN, Castellanos FX, Casey BJ, Kozuch P, King AC, Hamburger SD, Rapoport JL (1994) Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry 151:665-669
21. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS et al (2001) Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 40:1352-1355
22. Hoeppner J, Kunesch E, Buchmann J, Hess A, Grossmann A, Benecke R (1999) Demyelination and axonal degeneration in corpus callosum assessed by analysis of transcallosally mediated inhibition in multiple sclerosis. Clin Neurophysiol 110:748-756
23. Hoeppner J, Kunesch E, Großmann A, Tolzin C-J, Schulz M, Schläfke D, Ernst K (2000) Dysfunction of transcallosally mediated inhibition and callosal morphology in patients with schizophrenia. Acta Psychiatr Scand 104:227-235
24. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D, Lyytinen H (1991) Corpus callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis of MRI. J Learn Disabil 24:141-146
25. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L (2005) Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 57:229-238
26. Keswani SC (2004) Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa. J Neurol Neurosurg Psychiatry 75:663; author reply 663
27. Kirschner J, Moll GH, Fietzek UM, Heinrich H, Mall V, Berweck S, Heinen F et al (2003) Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry 36:79-82
28. Lijffijt M, Kenemans JL, Verbaten MN, van Engeland H (2005) A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: deficient inhibitory motor control? J Abnorm Psychol 114:216-222
29. Lyoo IK, Noam GG, Lee CK, Lee HK, Kennedy BP, Renshaw PF (1996) The corpus callosum and lateral ventricles in children with attention-deficit hyperactivity disorder: a brain magnetic resonance imaging study. Biol Psychiatry 40:1060-1063
30. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565-576
31. Meyer BU (1992): Die Magnetstimulation des Nervensystems. Springer, Berlin
32. Meyer BU, Roericht S, von Einsiedel GH, Kruggel F, Weindl A (1995) Inhibitory and excitatory interhemispheric transfer between motor cortical areas in normal subjects and patients with abnormalities of the corpus callosum. Brain 118:429-440
33. Meyer BU, Roericht S, Woiciechowsky C (1998) Topography of fibers in the human corpus callosum mediating interhemispheric inhibition between the motor cortices. Ann Neurol 43:360-369
34. Moll GH, Heinrich H, Trott G, Wirth S, Rothenberger A (2000) Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci Lett 284:121-125
35. Moll GH, Heinrich H, Rothenberger A (2001) Transcranial magnetic stimulation in child and adolescent psychiatry: excitability of the motor cortex system in tic disorders and/or attention deficit hyperactivity disorders. Z Kinder Jugendpsychiatr Psychother 29:312-323
36. Moll GH, Heinrich H, Rothenberger A (2003) Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention deficit hyperactivity disorder. Acta Psychiatr Scand 107(1):69-72
37. Musten LM, Firestone P, Pisterman S, Bennett S, Mercer J (1997) Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions. J Am Acad Child Adolesc Psychiatry 36:1407-1415
38. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:110-111
39. Pelham WE, Gnagy EM, Chronis AM, Burrows-MacLean L, Fabiano GA, Onyango AN, Meichenbaum DL et al (1999) A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 104:1300-1311
40. Perneger TV (1998) What's wrong with Bonferroni adjustments. BMJ 316:1236-1238
41. Porrino LJ, Lucignani G (1987) Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children. Biol Psychiatry 22:126-138
42. Roericht S, Irlbacher K, Petrow E, Meyer BU (1997) Normwerte transkallosal und kortikospinal vermittelter Effekte einer hemisphä renselektiven magnetischen Kortexreizung beim Menschen. EEG-EMG 28:34-38
43. Roesler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, Stieglitz RD et al (2004) Instrumente zur Diagnostik der Aufmerksamkeitsdefizit- /Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. Nervenarzt 75:888-895
44. Roesler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P (2006) Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 256(Suppl 1):i3-i11
45. Roessner V, Banaschewski T, Uebel H, Becker A, Rothenberger A (2004) Neuronal network models of ADHD - lateralization with respect to interhemispheric connectivity reconsidered. Eur Child Adolesc Psychiatry 13(Suppl 1):I71-79
46. Rossini PM, Rossi S (1998) Clinical applications of motor evoked potentials. Electroencephalogr Clin Neurophysiol 106:180-194
47. Schneider M, Retz W, Coogan A, Thome J, Roesler M (2006) Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD) - A neurological view. Eur Arch Psychiatry Clin Neurosci 256(Suppl 1):i32-i41
48. Srinivas NR, Hubbard JW, Quinn D, Midha KK (1992) Enantioselective pharmacokinetics and pharmacodynamics of dl-threo-methylphenidate in children with attention deficit hyperactivity disorder. Clin Pharmacol Ther 52:561-568
49. Srinivas NR, Hubbard JW, Korchinski ED, Midha KK (1993) Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans. Pharm Res 10:14-21
50. Swayze VW 2nd, Andersen AE, Andreasen NC, Arndt S, Sato Y, Ziebell S (2003) Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int J Eat Disord 33:33-44
51. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S et al (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463
52. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R et al (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331
53. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y et al (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21: RC121
54. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS et al (2002) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43:181-187
55. Ward MF, Wender PH, Reimherr FW (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885-890
56. Wender PH (1995) Attention-deficit hyperactivity disorder in adults. Oxford University Press, Oxford
57. Wender PH, Wolf LE, Wasserstein J (2001) Adults with ADHD. An overview. Ann N Y Acad Sci 931:1-16
58. Werhahn KJ, Fong JK, Meyer BU, Priori A, Rothwell JC, Day BL, Thompson PD (1994) The effect of magnetic coil orientation on the latency of surface EMG and single motor unit responses in the first dorsal interosseous muscle. Electroencephalogr Clin Neurophysiol 93:138-146
59. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J (1999) Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 517(Pt 2):591-597
60. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF (2005) Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57:1336-1346
61. Wolters A, Classen J, Kunesch E, Grossmann A, Benecke R (2004) Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes. Mov Disord 19:518-528
62. Ziemann U, Lonnecker S, Paulus W (1995) Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain 118(Pt 6):1437-1446
63. Ziemann U, Rothwell JC, Ridding MC (1996) Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 496(Pt 3):873-881